Examines the foundational role of research and development (R&D) in health preparedness and response, outlines how US agencies contribute to this work, and offers actionable policy recommendations to advance R&D to respond to COVID-19 and prepare for future health threats.
Examines how the US Agency for International Development’s (USAID) investments in global health innovation are an essential enabler in accelerating partner countries along the journey to self-reliance and explores challenges and opportunities the agency faces in advancing this work, providing actionable recommendations the Administration and Congress to maximize the impact of its health R&D activities.
Calls on G20 Heads of Government and Ministers to elevate health on the G20 agenda and prioritize investments in health innovation to deliver on the vision of health for all. The report looks at concrete examples of successful models, partnerships, mechanisms, and financing approaches that have accelerated the development and scale-up of global health technologies and system innovations, and provides recommendations to G20 policymakers that if implemented would increase momentum in global health innovation and strengthen the health and economies of all nations, whether high-, middle-, or low-income.
Provides analysis of the World Health Organization’s (WHO) draft Road Map for Access to Medicines, Vaccines and Other Health Products including an overview of the contents and the potential implications if approved. This roadmap, which outlines WHO’s proposed workplan on access for the period 2019–2023, will be presented to the WHO Executive Board in January 2018 for input and then will go before the World Health Assembly in May for endorsement.
Find out about GHTC’s membership options and the benefits of becoming a member.
Learn MoreWe bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.
